Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
https://www.cnbc.com/2024/02/01/merck-mrk-q4-earnings-report-2023.html
Feb 01, 2024 - Merck still posted a quarterly loss due to previously announced charges associated with its cancer drug collaboration deal with Daiichi Sankyo.
0
T. Rowe Price (TROW) to Post Q4 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2219670/t-rowe-price-trow-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2219670
Feb 01, 2024 - T. Rowe Price (TROW) is expected to have witnessed an improvement in AUM in the fourth quarter of 2023 due to favourable equity market performance partially offset by net outflows.
0
NXP Semiconductors (NXPI) to Post Q4 Earnings: What's in Store?
https://www.zacks.com/stock/news/2219668/nxp-semiconductors-nxpi-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2219668
Feb 01, 2024 - NXP Semiconductors' (NXPI) fourth-quarter results will likely reflect strength across Automotive and Industrial & IoT end markets. However, weakening demand in the Mobile segment may have been a concern.
0
Will Post Holdings (POST) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2218980/will-post-holdings-post-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2218980
Jan 31, 2024 - Post Holdings (POST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
https://www.cnbc.com/2024/01/31/gsk-posts-blowout-rsv-vaccine-sales-raises-outlook.html
Jan 31, 2024 - The RSV shot, called Arexvy, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.
0
Brunswick (BC) to Post Q4 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2218210/brunswick-bc-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2218210
Jan 30, 2024 - Brunswick's (BC) fourth-quarter performance is likely to have benefited from strong high-horsepower outboard engine demand, new model introductions and marketing and promotional activities.
0
Airline Stock Roundup: UAL & Others Post Q4 Earnings, AGT in Focus
https://www.zacks.com/stock/news/2218051/airline-stock-roundup-ual-others-post-q4-earnings-agt-in-focus?cid=CS-ZC-FT-analyst_blog|stock_roundup-2218051
Jan 30, 2024 - American Airlines (AAL) expects to incur a loss in first-quarter 2024. Allegiant's (ALGT) December traffic report disappoints.
0
Church & Dwight (CHD) Gears up for Q4 Earnings: What to Note?
https://www.zacks.com/stock/news/2218050/church-dwight-chd-gears-up-for-q4-earnings-what-to-note?cid=CS-ZC-FT-analyst_blog|earnings_preview-2218050
Jan 30, 2024 - Church & Dwight (CHD) is likely to have seen growth in Q4 earnings, supported by strategic initiatives and consumer demand despite the potential impacts of increased expenses.
0
Amazon (AMZN) to Post Q4 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2217418/amazon-amzn-to-post-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217418
Jan 29, 2024 - Amazon's (AMZN) fourth-quarter results are likely to reflect strong momentum across Prime and AWS.
0
Otis Worldwide (OTIS) to Post Q4 Earnings: What's in Store?
https://www.zacks.com/stock/news/2217416/otis-worldwide-otis-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217416
Jan 29, 2024 - Otis Worldwide's (OTIS) fourth-quarter results are expected to reflect the fluctuations in foreign currency exchange rates.
0